ORYZON GENOMICS, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 09/12/2019 15:45 ORYZON GENOMICS, S.A. R&D: new licenses, patents and registered trademarks Oryzon presents new positive efficacy data of iadademstat from the Phase IIa ALICE trial in AML Register number: 284280